MPI Research announced today that the enhancement of the ADME Laboratory is ready to serve its Sponsors. Under the direction of Craig Struble, Ph.D., MPI Research can conduct a full range of studies in support of both discovery and development projects. As the industry standard, whole-body radiograph tissue excision is still accepted; however, we can customize study designs based on sponsors’ needs. Most of the specialized studies include absorption studies whereby radiochemicals are used to identify and define results to suit the clients specifications or requirements. Fetal transfer studies with tissue distribution are conducted to support NCE package requirements. We can also produce radioactive dose preparations and custom radio purity analysis for dose preparations on site.

James Laveglia, Ph.D., Executive Vice President and Director of Research, commented, “Our ADME laboratory can support your high throughput drug discovery research programs.”

MPI Research exists to provide non-clinical research that meets the requirements of pharmaceutical, animal health and chemical companies as well as governmental agencies, as they develop products for a healthier world. MPI employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, analytical chemistry, computer science, regulatory science, and statistics.

Home | News